Niamh Rice1, Ioannis Polyzois2, Kumara Ekanayake3, Osama Omer2, Leo F A Stassen3. 1. Department of Oral and Maxillofacial Surgery, Oral Medicine, Oral Pathology, Dublin Dental University Hospital, Lincoln Place, Dublin 2, Ireland. Electronic address: nrice@tcd.ie. 2. Department of Restorative Dentistry and Periodontology, Dublin Dental University Hospital, Lincoln Place, Dublin 2, Ireland. 3. Department of Oral and Maxillofacial Surgery, Oral Medicine, Oral Pathology, Dublin Dental University Hospital, Lincoln Place, Dublin 2, Ireland.
Abstract
PURPOSE: To review the conservative and surgical management options of osteoradionecrosis, in particular, highlighting the recent the use of anti-radiation fibrosis drugs (pentoxifylline, tocopherol and clodronate). MATERIAL AND METHODS: We performed a literature review. The management options were divided into two groups, conservative and surgical management. RESULTS: Over the years several treatment options have been proposed including; conservative management (antibiotics, analgesics, oral hygiene), ultrasound therapy, hyperbaric oxygen therapy, surgical resection with reconstruction and more recently the use of anti-radiation fibrosis drugs (pentoxifylline, tocopherol and clodronate). Early or low grade ORN can be managed conservatively using a combination of treatment options. In advanced or refractory cases of ORN (pathological fracture, orocutaneous fistula) surgical treatment, at present, remains the only treatment option available. A new understanding of the pathophysiology of ORN (radiation induced fibroatrophic process) has lead to the development of new therapeutic management regimes. CONCLUSION: In advanced or refractory cases of ORN surgical treatment, including microvascular reconstructive techniques for bone and soft tissue, remains the only option available.
PURPOSE: To review the conservative and surgical management options of osteoradionecrosis, in particular, highlighting the recent the use of anti-radiation fibrosis drugs (pentoxifylline, tocopherol and clodronate). MATERIAL AND METHODS: We performed a literature review. The management options were divided into two groups, conservative and surgical management. RESULTS: Over the years several treatment options have been proposed including; conservative management (antibiotics, analgesics, oral hygiene), ultrasound therapy, hyperbaric oxygen therapy, surgical resection with reconstruction and more recently the use of anti-radiation fibrosis drugs (pentoxifylline, tocopherol and clodronate). Early or low grade ORN can be managed conservatively using a combination of treatment options. In advanced or refractory cases of ORN (pathological fracture, orocutaneous fistula) surgical treatment, at present, remains the only treatment option available. A new understanding of the pathophysiology of ORN (radiation induced fibroatrophic process) has lead to the development of new therapeutic management regimes. CONCLUSION: In advanced or refractory cases of ORN surgical treatment, including microvascular reconstructive techniques for bone and soft tissue, remains the only option available.
Authors: Ahmed Sultan; Glenn J Hanna; Danielle N Margalit; Nicole Chau; Laura A Goguen; Francisco M Marty; Guilherme Rabinowits; Jonathan D Schoenfeld; Stephen T Sonis; Tom Thomas; Roy B Tishler; Nathaniel S Treister; Alessandro Villa; Sook-Bin Woo; Robert Haddad; Hani Mawardi Journal: Oncologist Date: 2017-02-16
Authors: Hillary Nepon; Tyler Safran; Edward M Reece; Amanda M Murphy; Joshua Vorstenbosch; Peter G Davison Journal: Semin Plast Surg Date: 2021-09-10 Impact factor: 2.195
Authors: Suad Aljohani; Riham Fliefel; Teresa Franziska Brunner; Aristeidis Chronopoulos; Nada Binmadi; Sven Otto Journal: J Int Med Res Date: 2022-06 Impact factor: 1.573